Delivery Order SPE2DB22D9239-SPE2DB24FDF40
Award Date 12/27/23
Potential Completion Date 1/19/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NPLATE 250 MCG VIALS. The contract, valued at $10,167.36, has an ultimate completion date of June 20, 2024 and was awarded on May 29, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, worth $16,945.60, is for the supply of NPLATE 250 MCG VIALS and has a completion date of February 22, 2024. DMS Pharmaceutical Group is an experienced prime contractor for DLA, holding a multi-year indefinite delivery contract valued up to $4,999,999 to provide a wide range of pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,945.60 contract is for the delivery of NPLATE 250 MCG VIALS with a completion date of March 21, 2024. This award is under DMS Pharmaceutical Group's existing indefinite delivery contract #4600082013 with the DLA, which enables the agency to issue delivery orders for a broad range of pharmaceutical items to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4564883742 units of NPLATE 500 MCG VIALS. The contract has a ceiling value of $20,427.66 and runs through July 2, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a wide range...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply 250 mcg vials of Nplate. The $9,340.20 order has a completion date of December 4, 2023 and was awarded on November 9, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to military treatment pharmacies globally,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $15,567 to supply 250 mcg vials of Nplate to the Defense Logistics Agency under an indefinite delivery contract. As a woman-owned small business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various contracts with the Defense Logistics Agency to provide prescription drugs and medical supplies in support of military treatment facilities worldwide. This delivery order for Nplate...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $21,874.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NPLATE 250 MCG VIALS, with a performance period ending on May 14, 2024. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with DLA, valued at up to $499,999,999,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,340.20 firm fixed price order is for the medication NPLATE 250 MCG VIALS, with a completion date of January 18, 2024. DMS Pharmaceutical Group holds a broad pharmaceutical prime vendor contract with DLA Troop Support Medical to provide a variety of prescription drugs and medical supplies to military treatment facilities...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,694.68 contract is for the delivery of NPLATE 250 MCG VIALS, a specialized pharmaceutical product, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $10,045.59, is for the supply of 4567869011 NPLATE 500 MCG VIALS. The contract has an ultimate completion date of April 28, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDF40Delivery Order
The Defense Logistics Agency has awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical product NPLATE 250 MCG VIALS. The contract has a potential value of $15,567.00 and a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the Department of Defense through various indefinite delivery contracts and delivery orders. This specific award is not associated with a set-aside program.
Generated 3/27/24, 10:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 12/27/23 |